Metoclopramide - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:24Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:57, 20 March 2026
Line 137:		Line 137:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:26:25Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:26, 20 March 2026
Line 139:		Line 139:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:44:28Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:44, 20 March 2026
Line 126:		Line 126:

	==Comments==		==Comments==


			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Metoclopramide]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

Elcatracho: /* General */

2021-03-07T23:06:32Z

General

← Older revision		Revision as of 23:06, 7 March 2021
Line 1:		Line 1:
	==General==		==General==
	*Type: [[antiemetics]]		*Type: [[antiemetics]]
	*Dosage Forms: 5, 10; 5/5 mL; IM; IV		*Dosage Forms: 5mg, 10mg; 5mg/5 mL; IM; IV
	*Common Trade Names: Reglan		*Common Trade Names: Reglan

Elcatracho: /* Adverse Reactions */

2021-03-03T16:51:28Z

Adverse Reactions

← Older revision		Revision as of 16:51, 3 March 2021
Line 73:		Line 73:
	*parkinsonism		*parkinsonism
	*tardive dyskinesia		*tardive dyskinesia
	*neuroleptic malignant syndrome		*[[neuroleptic malignant syndrome]]
	*seizures		*seizures
	*depression		*depression

ClaireLewis at 23:25, 22 September 2019

2019-09-22T23:25:21Z

← Older revision		Revision as of 23:25, 22 September 2019
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~anti-emetic~~		*Type: [[antiemetics]]
	*Dosage Forms: 5, 10; 5/5 mL; IM; IV		*Dosage Forms: 5, 10; 5/5 mL; IM; IV
	*Common Trade Names: Reglan		*Common Trade Names: Reglan
Line 132:		Line 132:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:GI]]

Mholtz: Text replacement - "qid" to "QID"

2017-07-07T08:35:04Z

Text replacement - "qid" to "QID"

← Older revision		Revision as of 08:35, 7 July 2017
Line 30:		Line 30:
	==Pediatric Dosing==		==Pediatric Dosing==
	===GERD===		===GERD===
	*0.1-0.2mg/kg PO/IM/IV ~~qid~~		*0.1-0.2mg/kg PO/IM/IV QID
	*Max: 0.8mg/kg/24h x 12wk		*Max: 0.8mg/kg/24h x 12wk

Rossdonaldson1 at 03:50, 17 May 2017

2017-05-17T03:50:09Z

← Older revision		Revision as of 03:50, 17 May 2017
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	~~'''~~GERD~~''': chronic~~ symptoms: 10-15mg PO/IM/IV qac and qhs, Max: x12wk; intermittent symptoms: up to 20mg PO/IM/IV x 1 before symptoms		===[[GERD]]===
			*Chronic symptoms: 10-15mg PO/IM/IV qac and qhs
			*Max: x12wk; intermittent symptoms: up to 20mg PO/IM/IV x 1 before symptoms

	~~'''diabetic~~ gastroparesis~~''':~~ 10mg PO/IM/IV qac and qhs, Max: x12wk		===[[Diabetic gastroparesis]]===
			*10mg PO/IM/IV qac and qhs
			*Max: x12wk

	~~'''nausea~~/vomiting prevention, chemo-related~~''':~~ 1-2mg/kg IV q2-3h		===[[Nausea/vomiting]] prevention, chemo-related===
			*1-2mg/kg IV q2-3h

	~~'''nausea~~/vomiting prevention, postop~~''':~~ 10mg IM/IV x 1		===[[Nausea/vomiting]] prevention, postop===
			*10mg IM/IV x 1

	~~'''~~small bowel intubation~~''':~~ 10mg IV x 1		===small bowel intubation===
			*10mg IV x 1

	~~'''radiologic~~ exam~~''':~~ 10mg IV x 1		===Radiologic exam===
			*10mg IV x 1

	~~'''palliative~~ medicine~~:''~~ 10mg subcutaneously or orally 6-hourly and/or 30mg via [[CSCI]] over 24 hours		===Palliative medicine===
			*10mg subcutaneously or orally 6-hourly and/or 30mg via [[CSCI]] over 24 hours

	==Pediatric Dosing==		==Pediatric Dosing==
	~~'''~~GERD~~''':~~ 0.1-0.2mg/kg PO/IM/IV qid, Max: 0.8mg/kg/24h x 12wk		===GERD===
			*0.1-0.2mg/kg PO/IM/IV qid
			*Max: 0.8mg/kg/24h x 12wk

	~~'''nausea~~/vomiting prevention, chemo-related~~''':~~ 1-2mg/kg IV q2-4h		===[[Nausea and vomiting (peds)\|Nausea/vomiting]] prevention, chemo-related===
			*1-2mg/kg IV q2-4h

	~~'''nausea~~/vomiting prevention, postop~~''':~~ 0.1-0.2mg/kg IV x1		===[[Nausea and vomiting (peds)\|Nausea/vomiting]] prevention, postop===
			*0.1-0.2mg/kg IV x1

	==Special Populations==		==Special Populations==

Rossdonaldson1: Text replacement - "CHF" to "CHF"

2016-09-24T17:46:45Z

Text replacement - "*CHF" to "*CHF"

← Older revision		Revision as of 17:46, 24 September 2016
Line 69:		Line 69:
	*agranulocytosis		*agranulocytosis
	*methemoglobinemia		*methemoglobinemia
	*CHF, acute		*[[CHF]], acute
	*AV block		*AV block
	*SVT		*SVT

Rossdonaldson1: Text replacement - "HTN" to "hypertension"

2016-07-30T21:30:30Z

Text replacement - "HTN" to "hypertension"

← Older revision		Revision as of 21:30, 30 July 2016
Line 45:		Line 45:
	*caution if Parkinson disease		*caution if Parkinson disease
	*caution if NADH methemoglobin reductase deficiency		*caution if NADH methemoglobin reductase deficiency
	*caution if ~~HTN~~		*caution if hypertension
	*caution if CHF		*caution if CHF
	*caution if cirrhosis		*caution if cirrhosis
Line 72:		Line 72:
	*AV block		*AV block
	*SVT		*SVT
	*~~HTN~~		*hypertension
	*angioedema		*angioedema
	*hepatotoxicity		*hepatotoxicity
Line 96:		Line 96:
	*fluid retention		*fluid retention
	*hypotension		*hypotension
	*~~HTN~~		*hypertension
	*bradycardia		*bradycardia
	*nausea		*nausea